It’s essential to understand how to properly read and analyze the results to unlock accurate and meaningful insights. Whether you’re working with DNA, RNA, or another type of genetic data, investigators must approach datasets thoughtfully, recognize their unique characteristics, and remain alert to any weaknesses that could limit their ability to draw meaningful conclusions.
Copenhagen, Denmark, October 7th, 2024 – Clinical Microbiomics A/S (“CMC”), a leading innovator in multi-omics, bioinformatics and systems biology for the microbiome field, based in Copenhagen, Denmark, announces that the company has entered into a definitive agreement whereby Microba Life Sciences Limited (“Microba”) transfers its Research Services business unit to CMC. The deal supports CMC’s ambition to increase access to...
The microbiome industry is experiencing rapid growth and transformation, driven by advancements in sequencing technologies, increased funding, and innovative research. This blog article compiles 40 key statistics that highlight the significant changes and trends in the microbiome field in 2024. Covering aspects from market size and segmentation to machine learning applications and insights from major...
Offering Unparalleled Resolution and Quality in Microbial Analysis Copenhagen, Denmark — April 23, 2024 — Clinical Microbiomics, a leader in microbiome analysis, announces the launch of its advanced long-read sequencing services. Tailored to meet the stringent requirements of academic, clinical, and industrial researchers, the expanded offerings deliver unmatched insights into microbial communities, featuring the industry’s...
Durham, NC (March 21, 2024 ) – Resilient Biotics, a leading microbiome platform company with a pipeline of products for maintaining respiratory tract health, is thrilled to announce a groundbreaking collaboration with CosmosID, a renowned microbiome analytics company. This joint effort aims to explore the intricate microbiome strains that colonize the respiratory tract tissues, a...
Clinical Microbiomics A/S^1, the global microbiome science company, today announces the acquisition of DNASense ApS, an innovative Danish microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics.
In the intricate world of microbiology and bacterial identification, 16S sequencing plays a pivotal role. But a common query often perplexes scientists and enthusiasts alike: Does 16S sequencing target RNA or DNA? This article will unravel the mysteries surrounding amplicon sequencing, exploring its role in bacterial identification, the distinction between 16S rRNA and whole genome...
Microbial growth is a dynamic and intricate process crucial for the survival and proliferation of bacterial cells. Understanding the sequential order of microbial growth stages is fundamental for researchers, microbiologists, and anyone delving into the fascinating realm of microbiology. In this comprehensive guide, we will explore the four stages of microbial growth—lag, exponential (log), stationary,...
In the captivating world of microbiology, two primary methods have emerged to study the composition, structure, and function of microbial communities: 16S ribosomal RNA (rRNA) gene sequencing and metagenomics. This article will delve into a comparative analysis of these two techniques. We will explore their fundamental principles and methodologies of each sequencing method, before looking...
Clinical Microbiomics A/S, a leading innovator in bioinformatics and systems biology for the microbiome field based in Copenhagen, Denmark, announces the merger with CosmosID Inc, a leading CLIA-certified, GxP-compliant microbiome CRO based in Germantown, Maryland, United States.
© 2023 CosmosID. All rights reserved